Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-blockers in heart failure.

O I Sleiman1, J Murin, W M Ghanem

  • 1Ist Department of Internal Medicine, Medical Faculty, Comenius University and University Hospital, Bratislava, Slovakia. Ossamasleiman@hotmail.com

Bratislavske Lekarske Listy
|December 1, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Central systolic blood pressure (cSBP) to brachial systolic blood pressure (brachSBP) ratio reproducibility during antihypertensive therapy.

Bratislavske lekarske listy·2021
Same author

Central systolic blood pressure increases with aortic stiffness.

Bratislavske lekarske listy·2019
Same author

Holter ECG findings in diabetics with medial arterial calcification.

Bratislavske lekarske listy·2019
Same author

The use of antiplatelet medication in hospitalised elderly patients.

Bratislavske lekarske listy·2015
Same author

Suboptimal use of gastroprotective medication in elderly antiplatelet users.

Bratislavske lekarske listy·2015
Same author

[Cardiorenal syndrome by heart failure].

Vnitrni lekarstvi·2013
Same journal

Imunological aspects of kidney retransplantation.

Bratislavske lekarske listy·2024
Same journal

The effect of lengthening of the percutaneous implant in the surgical treatment of Th-L ankylosed spine fractures: 4 segment fixation versus 5 to 8 segment fixation.

Bratislavske lekarske listy·2024
Same journal

Prostate cancer in Slovakia: last decade overview.

Bratislavske lekarske listy·2024
Same journal

Cancer epidemiology in Slovakia.

Bratislavske lekarske listy·2024
Same journal

Peculiarities of nutritional support in patients with neoplasms of the hepatopancreatoduodenal zone as a component of intensive therapy in the postoperative period.

Bratislavske lekarske listy·2024
Same journal

A comparative review of coronary computed tomography angiography and myocardial perfusion imaging.

Bratislavske lekarske listy·2024
See all related articles

Beta-blockers are now recommended for heart failure (HF) patients, a significant shift from previous contraindications. These medications are crucial for reducing mortality and morbidity in HF patients with reduced ejection fraction.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Heart failure (HF) management has evolved significantly.
  • Beta-blockers were historically contraindicated in HF patients.
  • Current guidelines now advocate for beta-blocker use in HF.

Purpose of the Study:

  • To analyze major studies on beta-blocker use in heart failure.
  • To emphasize the benefits of beta-blockers in HF treatment.
  • To promote wider application of beta-blockers in HF patients.

Main Methods:

  • Review and analysis of key clinical trials involving beta-blockers and HF.
  • Examination of treatment protocols and patient outcomes.

Main Results:

  • Beta-blockers demonstrate significant benefits in reducing mortality and morbidity in HF patients.

Related Experiment Videos

  • Evidence supports the use of beta-blockers in HF with reduced ejection fraction.
  • Specific recommendations exist for safe and effective beta-blocker administration.

    • Conclusions:

    • Beta-blockers should be used in all patients with HF and reduced ejection fraction unless a contraindication exists.
    • The benefits of beta-blockers in improving HF outcomes are well-established.
    • Increased utilization of beta-blockers is essential for optimal HF care.